A further strategy to combat the high price of anticancer drugs
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.136
Published Online: 2017-08-22
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gilbar, Peter J.
Text and Data Mining valid from 2017-08-22
Article History
First Online: 22 August 2017
Competing interests
: The author declares no competing financial interests.